Doug Densmore, Ph.D.
Co-founder and President

Doug is an expert in Synthetic Biology and one of the founders of Bio-Design Automation (BDA) as a discipline. He is currently a Kern Faculty Fellow, a Hariri Institute for Computing and Computational Science and Engineering Faculty Fellow, and Associate Professor in the Department of Electrical and Computer Engineering at Boston University. He is an NSF CAREER Award recipient and was an affiliated PI with NSF’s SynBERC. Related activities include: President of the Bio-Design Automation Consortium; President of the Nona Research Foundation; Founder and general chair of the International Workshop on Bio-Design Automation (IWBDA); Member of the MIT/Broad Foundry Development Team; NSF Expeditions in Computing Lead PI (“Living Computing Project”).

Kevin LeShane
Vice President, Head of Software Engineering

Kevin has a Masters degree in Computer Engineering from Boston University and was a contributor to algorithms and user experience for core software projects (Clotho, Raven, Phoenix) in the Cross-disciplinary Integration of Design Automation Research lab. He was the recipient of an NSF SBIR Phase I award: "Commercialization of Bio-Design Automation Software for Synthetic Biology" and most recently an NSF SBIR Phase II award: "Fully Integrated Design and Automated Fabrication Services Software Platform for Engineering Living Systems".


Jenny Rooke, Ph.D.

Jenny Rooke is Managing Director at 5 Prime Ventures, where she invests in early stage life sciences companies, specializing in research tools, diagnostics, and synthetic biology. Jenny’s investing experience includes roles at F-Prime Capital, where she served her Kauffman Fellowship, Anterra Capital, and the Bill & Melinda Gates Foundation. Prior to investing, Jenny held multiple senior operating roles at U.S. Genomics, a venture-backed biotech start-up advancing single molecule detection technologies, and consulted to pharma and biotech companies with McKinsey & Co. Dr. Rooke holds a PhD in genetics from Yale University and a BS in Physics from Georgia Tech.

Amoolya Singh, Ph.D.

Amoolya is a Director at Amyris. She leads Amyris R&D's Scientific Computing group, whose work includes innovations in genotype representation and data visualization; metabolic modeling and design-of-experiments to perturb microbial biochemical pathways; and statistical process control to accelerate Amyris' design-build-test-learn cycle. Amoolya obtained a Ph.D. in computational biology from UC Berkeley. Prior to joining Amyris, Amoolya completed a postdoctoral fellowship at the European Molecular Biology Lab in Heidelberg, Germany (with Peer Bork) and a Computational & Life Sciences fellowship at Emory University (with Bruce Levin) in the fields of comparative genomics and metagenomics, population genetics, and experimental evolution.